Ginger and psoriatic arthritis: IL-17, IL-23, TNF-α, and enthesitis — immuno-inflammatory mechanisms

⚡ Direct Answer: Ginger inhibits the IL-23/IL-17 axis (a central pathway in psoriatic rheumatism and ankylosing spondylitis), reduces enthesitis via peritendinous NF-κB, inhibits TNF-α and bone RANKL (↓ bone erosions), and activates Nrf2 to protect entheseal chondrocytes. The sugar in INTI vs GIMBER comparative analysis (~35g/100ml) exacerbates the Th17 axis via NF-κB → counterproductive in spondyloarthropathies.

Spondyloarthropathies: Beyond Classic RA

Spondyloarthropathies (SpA) constitute a group of inflammatory joint diseases distinct from RA:

Their central mechanism: IL-23/IL-17 axis — IL-23 (produced by macrophages and dendritic cells) differentiates Th17 → IL-17A → articular, entheseal, and bone inflammatory cascade. IL-17 is the primary therapeutic target (secukinumab, ixekizumab).

Mechanisms of Ginger in SpA

1. Inhibition of the IL-23/IL-17 axis (cholesterol-tension-protection-2026">core of SpA)

Ginger inhibits IL-17 via:

  • Reduction of STAT3 (essential transcription factor for IL-23-induced Th17 differentiation)
  • Inhibition of RORγt (master transcription factor of Th17)
  • Direct reduction of IL-17A, IL-17F expression in activated Th17 cells

Additionally, ginger inhibits NF-κB in macrophages → ↓ IL-23 production → less upstream Th17 differentiation.

2. Reduction of enthesitis (anti-inflammatory-inflammation-natural-remedy">inflammation of entheses)

The enthesis (tendon-bone junction) is the primary pathogenic site of SpA. IL-17 and TNF-α induce NF-κB in enthesocytes → overproduction of local cytokines and metalloproteinases. Ginger inhibits NF-κB in enthesocytes → ↓ local IL-6, MMP-3 → less enthesitis → ↓ mechanical pain at entheses.

3. Bone Protection: RANKL and Erosions

In PR and AS, IL-17 and TNF-α stimulate RANKL in enthesocytes and osteoblasts → osteoclasts → bone erosions. Ginger inhibits NF-κB → ↓ RANKL → ↓ entheseal osteoclasts → fewer periarticular bone erosions.

4. Action on cutaneous psoriasis (comorbidity of PR)

PR is always associated with cutaneous psoriasis (85% of cases). Psoriasis is also IL-17-mediated (cutaneous Th17 → IL-17 → keratinocytes → proliferation). Ginger inhibits IL-17 and NF-κB in keratinocytes → simultaneous reduction of cutaneous and articular psoriasis.

5. Inhibition of TNF-α (shared PR/SpA cytokine)

TNF-α is common to RA and SpA — it amplifies IL-17, activates NF-κB in enthesocytes and chondrocytes. Ginger inhibits TNF-α via NF-κB → cross-reduction of both inflammatory pathways.

Ginger and spondyloarthropathies: mechanisms
Target Role in SpA Ginger effect
IL-23 (macrophages) Th17 differentiation ↑ NF-κB ↓ macrophages → IL-23 ↓
IL-17A/F (Th17) Entheseal/bone/skin inflammation STAT3 ↓, RORγt ↓ → IL-17 ↓
NF-κB enthesocytes Enthesitis → mechanical pain NF-κB ↓ → IL-6, MMP-3 ↓
Bone RANKL Bone erosions RANKL ↓ → osteoclasts ↓
TNF-α Amplification of SpA cascade TNF-α ↓ via NF-κB
NF-κB keratinocytes Cutaneous psoriasis Reduction of cutaneous comorbidity

GIMBER and SpA: The Th17 Sugar Aggravator

  • Sugar → systemic NF-κB → macrophages → IL-23 ↑ → Th17 ↑ → IL-17 ↑ → aggravated SpA
  • Fructose → AGE → RAGE → NF-κB → amplified entheseal inflammation
  • Obesity (AMPK ↓ + ginger insulin ↑) → adipokines (leptin, altered adiponectin) → pro-inflammatory Th17
❓ FAQ — Ginger and spondyloarthropathies

Q: Does ginger replace anti-IL-17 (secukinumab) in PR/AS?
A: No. Secukinumab is the reference biological treatment for moderate to severe SpA. Ginger shares the IL-17 ↓ mechanism but with much lower potency. It can complement treatment but never replace it. Consult a rheumatologist.

Q: Are there studies on ginger and PR/AS specifically?
A: Direct studies are limited. The IL-17/Th17 mechanisms documented for ginger are extrapolated from studies on RA and spondyloarthritis in general. More specific clinical studies are needed.

Q: Does sugar worsen psoriatic rheumatism?
A: Yes — obesity (correlated with sugar consumption) is a risk factor for PR and worsens its activity. TNF-α and IL-17 are higher in obese PR patients.

🌿 Conclusion: Ginger inhibits the central IL-23/IL-17 axis of SpA, reduces enthesitis, bone erosions, and cutaneous psoriasis. For these benefits without exacerbating the Th17 axis with sugar, choose INTI — organic artisanal ginger preparation, 1.19g/100ml. The anti-inflammatory-science-utilisation">anti-inflammatory ginger drink for spondyloarthropathies.

Related articles

To delve deeper into the subject, also read:

Back to blog